Nektar Therapeutics (NASDAQ:NKTR) Shows Positive Preclinical Data on Kappa Agonist Molecules

Boston, MA 09/22/2014 (wallstreetpr) – Nektar Therapeutics (NASDAQ:NKTR) recently announced results from preclinical studies and characterized analgesic profiles of a many of the kappa opioid receptor agonist molecules which act peripherally. Nektar’s medicinal chemistry platform for small molecule was utilized by the company to create preclinical research candidates. The analgesic properties of agonist kappa receptors […]